#Axelyf
#icemade #biotech company #Axelyf has raised $2.6M in seed funding, with the round expected to reach $4.1M later this year. By @arcticstartup https://arcticstartup.com/axelyf-raises-2-6-million-seed/ #NordicMade #rvktech #icelandicstartups @IcelandStartups
Iceland’s Axelyf raises $2.6M seed round to develop RNA delivery technologies | ArcticStartup
arcticstartup.com
August 29, 2025 at 6:47 PM
At @elrig.org Research & Innovation, we spoke to Örn Almarsson about the therapeutic potential of mRNA lipid nanoparticles, highlighting why and how Axelyf is developing them >>> www.biotechniques.com/drug-discove... 🧪
Developing and delivering mRNA lipid nanoparticle therapeutics
We spoke to Örn Almarsson about the therapeutic potential of mRNA lipid nanoparticles and the techniques being used to develop them.
www.biotechniques.com
May 27, 2025 at 1:08 PM
📊 Biotech VC Weekly Roundup: Early-stage deals span oncology, infectious disease & diagnostics. Notables: Arivin (anti-virulence), Axelyf (RNA delivery), EnsiliTech (vaccine stabilization), Detechgene (portable PCR).

→ www.ventureradar.com/articles/Adv...

#Biotech #VC #Oncology #Diagnostics
Advances in Oncology, Infectious Disease, and Diagnostics | Biotech VC Deals Weekly Roundup | VentureRadar
Advances in Oncology, Infectious Disease, and Diagnostics | Biotech VC Deals Weekly Roundup
www.ventureradar.com
September 4, 2025 at 1:35 PM
Axelyf: the Moderna delivery vets who think the hard part of RNA medicine isn't the RNA - it's getting it where it needs to go.

https://yespress.io/axelyf?utm_source=bluesky&utm_medium=social via Yespress
Axelyf: The RNA Delivery Startup That Bet on the Lipid, Not the Payload
Ex-Moderna delivery vets, a four-series AXL lipid library, an AI named ANNA, and a $2.6M seed. Inside the company treating delivery as the real bottleneck in RNA medicine.
yespress.io
August 7, 2026 at 10:54 PM
Feed: "Inside Precision Medicine"
By: Jonathan D. Grinstein, PhD on Thursday, August 21, 2025
RNA-LNP Therapeutics Startup Axelyf Seeded to Conquer Delivery Challenges
Former Moderna executive Örn Almarsson, PhD, is betting on proprietary lipid chemistry and AI to unlock broader RNA therapeutic targets.
www.insideprecisionmedicine.com
August 22, 2025 at 1:33 AM
Axelyf Appoints Daniel Frímannsson, Ph.D., Head of Nucleic Acid Technologies & Biology and Leslie Williams to Board
rcnamericama.blogspot.com/2025/12/axel...
Axelyf Appoints Daniel Frímannsson, Ph.D., Head of Nucleic Acid Technologies & Biology and Leslie Williams to Board
rcnamericama.blogspot.com
December 16, 2025 at 6:43 PM